Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2003
12/11/2003WO2002096940A3 Attenuated very virulent infectious bursal disease virus
12/11/2003WO2002094228A9 Prevention and treatment of allergies by helminthic regulation of ige
12/11/2003WO2002094190A3 Heterologous protection induced by immunization with invaplex vaccine
12/11/2003WO2002083067A3 Prodrugs via acylation with cinnamate
12/11/2003WO2002075507B1 Anti-bacterial vaccine compositions
12/11/2003WO2002072013A3 Method of treating malignancies through induction of blood immune responses
12/11/2003WO2002064788A3 Compositions and methods relating to lung specific genes and proteins
12/11/2003WO2002043758A3 Uses of mammalian genes and related reagents
12/11/2003US20030229906 Preventing kidney cell dedifferentiation and viral nephropathy using peptide inhibitors; enzyme inhibitors; viricides; mimetics
12/11/2003US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors
12/11/2003US20030229209 Comprises mitogen-activated protein (MAP) kinase polypeptide for treating muscular, diabetic and nervous system disorders
12/11/2003US20030229208 Humanized immunoglobulins
12/11/2003US20030229207 Comprises immunoglobulin protein for preventing and treating transplant rejection, multiple sclerosis, autoimmune and graft-versus-host disease
12/11/2003US20030229199 Modulator comprising cyclic peptide for use in treatment of cancer, gastrointestinal, inflammatory and nervous system disordrers
12/11/2003US20030229044 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
12/11/2003US20030229021 Antiallergens
12/11/2003US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies
12/11/2003US20030228696 Novel insect cell line
12/11/2003US20030228676 Comprises nucleotide sequences coding proteolytic enzyme asociated with aggrecan degradation for treating degenerative joint diseases
12/11/2003US20030228672 Comprises nucleotide sequences coding oxidoreductases for transformation and fermentive production of 2-keto-L-gulonic acid
12/11/2003US20030228663 Polypeptides comprising light and variable chains domains for use in the treament of cancer
12/11/2003US20030228653 Novel orphan cytokine receptor polypeptides
12/11/2003US20030228638 Isolating endothelial cells from whole blood and detecting human leukocte antigen specific antibody complexes for diagnosing organ rejection, blood, wound healing and vascular diseases
12/11/2003US20030228634 Expression vectors encoding epitopes of target-associated antigens and methods for their design
12/11/2003US20030228587 IWU-1 is a protein of 115 amino acids with a calculated molecular mass of 12.9 kDa, cloned from a cDNA molecule of human bone marrow having 347 nucleotides
12/11/2003US20030228380 Central nervous system diosrders; reduction of estrogen after menopause
12/11/2003US20030228330 Prevent reproduction of poxvirus; genetic engineering; transcription control
12/11/2003US20030228329 Genetic engineering; insertion of gene; generating immunology response
12/11/2003US20030228327 Mixture of plasmids, protein which induce immunology response; Aids therapy
12/11/2003US20030228326 Administering antigen; anticancer agents; transfection human cells
12/11/2003US20030228325 Immunology active materials; complexing to major histocompatibility complex
12/11/2003US20030228323 Protein vaccine; culture product; genetic engineering
12/11/2003US20030228322 Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria
12/11/2003US20030228320 Administering activator of retrovirus cells; then suppressor or destroying cells
12/11/2003US20030228318 PSCA: prostate stem cell antigen and uses thereof
12/11/2003US20030228311 Methods for enhancing oral tolerance and treating autoimmune disease using inhibitors of interleukin-12
12/11/2003US20030228310 Autoimmune diseases; administering interferon antibody
12/11/2003US20030228308 Immunology active materials; complexing; anticancer agents
12/11/2003US20030228305 Compositions and methods for the diagnosis and treatment of tumor
12/11/2003US20030228300 Induce immunology response; vaccine for solid tumors; removal of cancer cells, enzyme digestion, irradiation; antitumor, anticancer agents
12/11/2003US20030228289 Universal chimera bank
12/11/2003US20030228282 Genetic engineered polypeptide; inserted into cell; blood disorders
12/11/2003US20030228281 Use of mutant herpes viruses and anticancer agents in the treatment of cancer
12/11/2003US20030228279 Compositions and methods for viral delivery
12/11/2003US20030228278 Immunotherapy of chronic infections and of malignant diseases
12/11/2003US20030228275 Immobilization of drugs
12/11/2003CA2736974A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736972A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2736926A1 Tumour associated peptides that bind to mhc molecules
12/11/2003CA2736921A1 Tumour-associated peptides that bind to mhc molecules
12/11/2003CA2491420A1 Rb1 gene induced protein (rb1cc1) and gene
12/11/2003CA2488568A1 Methods of diagnosing and treating diabetes and insulin resistance
12/11/2003CA2488281A1 Novel bacterium for treatment of disease
12/11/2003CA2488234A1 Immunomodulatory constructs and their uses
12/11/2003CA2487932A1 Cd16a binding proteins and use for the treatment of immune disorders
12/11/2003CA2487915A1 Allergen from mugwort pollen
12/11/2003CA2487904A1 Immunostimulatory oligonucleotides and uses thereof
12/11/2003CA2487897A1 Helper virus-free herpesvirus amplicon particles and uses thereof
12/11/2003CA2487724A1 Immunogenic sequences
12/11/2003CA2487692A1 Methods and compositions for radioimmunotherapy of brain and cns tumors
12/11/2003CA2486980A1 Attenuated listeria spp. and methods for using the same
12/10/2003EP1369483A1 Allergen from mugwort pollen
12/10/2003EP1369427A2 HIV-3 retrovirus strains and their use
12/10/2003EP1369132A1 Oxaliplatin containing liposome preparation
12/10/2003EP1369127A1 Novel medicinal use of aplpha antigen or alpha antigen gene
12/10/2003EP1369118A1 Process and agent for the prevention, inhibition and therapy of sepsis
12/10/2003EP1368660A2 Assay
12/10/2003EP1368478A2 Polypeptide inducing hiv-neutralising antibodies
12/10/2003EP1368477A1 Vaccine
12/10/2003EP1368459A2 Influenza viruses with enhanced transcriptional and replicational capacities
12/10/2003EP1368458A2 Interferon-alpha induced gene
12/10/2003EP1368457A1 Use of gram-negative bacterial membrane fraction for inducing the maturation of dendritic cells
12/10/2003EP1368456A2 Anti-bacterial vaccine compositions
12/10/2003EP1368377A2 Modified interferon beta with reduced immunogenicity
12/10/2003EP1368373A2 Environmentally regulated genes, involved in the virulence of streptococcus suis
12/10/2003EP1368372A2 Peptides having affinity for the gp120 viral protein and use thereof
12/10/2003EP1368371A2 Transfection complexes
12/10/2003EP1368061A2 Fusion cells and cytokine compositions for treatment of disease
12/10/2003EP1368060A1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
12/10/2003EP1368057A2 Method to enhance the immunogenicity of an antigen
12/10/2003EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders
12/10/2003EP1367998A2 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
12/10/2003EP1367997A1 Injectable water-in-oil emulsions
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1066058B1 Immunotoxin cocktails for the treatment of immune related diseases
12/10/2003EP1049711B1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
12/10/2003EP0996726B1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof
12/10/2003EP0964870B1 Lsr receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
12/10/2003EP0912611B1 Human monoclonal antibodies to the hepatitis b surface antigen
12/10/2003EP0889736B1 Iscom or iscom-matrix comprising a mucus targetting substance and an antigen
12/10/2003EP0754059B1 Methods and compositions useful for inhibition of angiogenesis
12/10/2003EP0724456B1 Antibodies to cd40
12/10/2003EP0680316B1 Novel parasitic helminth proteins
12/10/2003EP0679191B1 Detection and treatment of mutations in a cd40 ligand gene
12/10/2003EP0666914B1 Novel p-selectin ligand protein
12/10/2003CN1461344A Multivalent target binding protein
12/10/2003CN1461338A Temperature-sensitive live vaccine for mycoplasma hyopneumoniae
12/10/2003CN1461310A ANtibodies that bind human interleukin-18 and methods of making and using
12/10/2003CN1461211A Microparticles for pulmonary administation
12/10/2003CN1460686A Method for preparing alpha-fetoglobulin transspecific factor
1 ... 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 ... 1823